Table 4.
Effects of disease mutations on conformational dynamics
Effect | Disease Associated | Gene/Mutation | Reference |
---|---|---|---|
Conformational Flexibility | Diabetes and Cancer | PTEN; H61D | 128 |
Multiple Diseases | cNTnC; L48Q | 184 | |
Conformational Diseases | α(1)-antitrypsin variant; K154N | 129 | |
Variegate Porphyria Disorder | hPPO; R59Q, R59G | 130 | |
Colorectal Cancer | mitotic centromere-associated kinesin protein; E403K | 185 | |
Classic Galactosemia | GALT; multiple sites | 186 | |
Becker Muscular Dystrophy | dystrophin protein; L427P | 187 | |
| |||
Disordered Regions | Parkinson disease | α-synuclein; multiple sites | 133 |
Ovarian Cancer | HPV proteins; multiple sites | 133 | |
Cancer | p53 protein; multiple sites | 133 | |
Huntington’s disease | huntingtin; multiple sites | 133 | |
| |||
Order-Disorder Transitions | Stargardt Disease (type 1) | Multiple mutations | 188 |
Adrenoleukodystrophy X-linked | Multiple mutations | 188 | |
Androgen Insensitivity Syndrome | Multiple mutations | 188 | |
Citrullinemia (type 1) | Multiple mutations | 188 | |
| |||
Aggregation | Alpha(1)-antitrypsin Deficiency and Cystic Fibrosis | human serine protease inhibitor (serpin) α-1 antitrypsin; E342K | 140; 189 |
Creutzfeldt-Jakob disease and Gerstmann-Straussler-Scheinker Disease | prion protein; multiple sites | 141 | |
| |||
Local Motion | Cancers | KLK3; multiple sites | 190; 191; 192 |